Degarelix Injection 120mg is a prescription-only hormonal therapy widely used in the treatment of advanced and hormone-dependent prostate cancer. It is clinically proven to help control cancer progression by effectively lowering testosterone levels, a key hormone that fuels prostate cancer growth.

This injection contains degarelix, a potent GnRH (gonadotropin-releasing hormone) antagonist that works by directly blocking hormone signals from the pituitary gland. Unlike traditional hormone therapies, it reduces testosterone rapidly without causing an initial testosterone surge or flare, ensuring safer and faster disease management.

Degarelix Injection 120 mg is administered subcutaneously under medical supervision and is valued for its quick onset of action and reliable androgen suppression. It is an effective treatment option for patients requiring immediate and sustained testosterone control in advanced prostate cancer therapy.

Product Feature

• Hormonal prostate cancer treatment injection
• Contains Degarelix 120 mg
• GnRH antagonist with no testosterone flare
• Rapid and sustained testosterone suppression
• Subcutaneous injectable formulation
• Used in advanced and metastatic prostate cancer
• Manufactured under GMP-compliant quality standards
• Prescription-required specialty medicine

 

How It Helps

• Quickly reduces testosterone without an initial hormone flare
• Helps slow the growth and spread of prostate cancer cells
• Provides effective and sustained androgen suppression
• Supports better symptom control in advanced and metastatic cases
• Improves treatment response when immediate testosterone control is required